RB1 and breast neoplasm: It is evaluated that RB1 and TP53 are lost together in 28–40% of human TNBCs, and RB/P53-double mutant mouse breast tumor cells exhibit more mesenchymal phenotypes than only P53-deficient cells (230, 231).